Putnam Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$35.9M Buy
117,061
+7,246
+7% +$1.96M 0.05% 164
2023
Q3
$26.6M Buy
109,815
+12,478
+13% +$3.19M 0.04% 174
2023
Q2
$23.4M Buy
97,337
+4,296
+5% +$892K 0.03% 189
2023
Q1
$17.5M Buy
93,041
+290
+0.3% +$60K 0.03% 223
2022
Q4
$19.7M Buy
92,751
+1,564
+2% +$312K 0.03% 195
2022
Q3
$14.3M Sell
91,187
-14,295
-14% -$2.28M 0.03% 234
2022
Q2
$15.8M Sell
105,482
-10,233
-9% -$1.48M 0.03% 230
2022
Q1
$18.9M Buy
115,715
+1,673
+1% +$276K 0.03% 231
2021
Q4
$24.8M Buy
114,042
+5,173
+5% +$1.08M 0.04% 225
2021
Q3
$20.6M Sell
108,869
-28
-0% -$5.11K 0.03% 237
2021
Q2
$19.2M Sell
108,897
-720
-0.7% -$124K 0.03% 253
2021
Q1
$18M Sell
109,617
-55
-0.1% -$8.41K 0.03% 274
2020
Q4
$15.3M Sell
109,672
-636
-0.6% -$80.2K 0.03% 287
2020
Q3
$12.3M Sell
110,308
-106
-0.1% -$12.3K 0.02% 304
2020
Q2
$10.3M Sell
110,414
-178
-0.2% -$15.1K 0.02% 321
2020
Q1
$8.12M Sell
110,592
-318
-0.3% -$27.6K 0.02% 354
2019
Q4
$9.32M Hold
110,910
0.02% 381
2019
Q3
$9.32M Buy
110,910
+2,046
+2% +$155K 0.02% 375
2019
Q2
$7.12M Hold
108,864
0.02% 439
2019
Q1
$6.42M Sell
108,864
-6,700
-6% -$400K 0.01% 453
2018
Q4
$6.12M Buy
+115,564
New +$6.34M 0.02% 425

Other funds holding MEDP

Putnam Investments's MEDP Position: Q4 2023 in Review

Putnam Investments increased its Medpace (MEDP) stake by 6.6% in Q4 2023, buying an estimated $1.96M and bringing the position to 117,061 shares worth $35.9M. The position accounts for 0.05% of the portfolio, ranked #164.

Putnam Investments first reported a position in MEDP in Q4 2018 and has held it in 21 quarters since. 544 funds tracked by Wall St. Rank hold MEDP as of Q4 2023.

  • Putnam Investments held 117,061 shares of Medpace worth $35.9M as of Q4 2023.
  • Putnam Investments bought 7,246 Medpace shares in Q4 2023, an estimated $1.96M.
  • Medpace made up 0.05% of Putnam Investments's portfolio in Q4 2023, its #164 holding.
  • Putnam Investments first reported a position in Medpace in Q4 2018 and has held it in 21 quarters since.
  • 544 funds tracked by Wall St. Rank held Medpace as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.